The administration of IGF-1 has been shown to preclude fibrosis and ameliorate liver function in a rat model of liver cirrhosis [83] and recovery of heart functions and inhibit myocardial fibrosis in a mouse model of dilated cardiomyopathies [84]. This evidence concerns the gene IGF1 and dilated cardiomyopathy.